Department of Pathology, University of Yamanashi, Yamanashi, Japan.
Department of Pathology, University of Yamanashi, Yamanashi, Japan
J Clin Pathol. 2019 Nov;72(11):736-740. doi: 10.1136/jclinpath-2019-206056. Epub 2019 Aug 30.
Evaluating peritoneal elastic laminal invasion (ELI) has been proposed as an additional assessment for pT3 colorectal cancers (CRC). Its clinical significance has not yet been established. We performed a meta-analysis to investigate the prognostic impact of ELI assessment for subcategorisation of pT3 CRC. We performed a search in three electronic databases. HR and its 95% CI for overall survival (OS) and disease-free survival (DFS) were calculated using the random effects model weighted by the inverse variance method. We identified six studies that met inclusion criteria out of an original 703 studies found with our database search terms. Our meta-analysis included 1925 patients with pT3 and pT4a CRCs. The presence of ELI in pT3 CRC was associated with shortened OS compared with ELI negative pT3 CRC (HR=1.76; 95% CI 1.21 to 2.55); whereas the DFS was not statistically significant (HR=1.79; 95% CI 0.91 to 3.52). Furthermore, pT4a patients' OS (HR=1.84; 95% CI 1.41 to 2.40) and DFS (HR=1.88; 95% CI 1.17 to 3.04) were even worse than the OS and DFS of pT3 ELI (+) patients. ELI is a useful marker for stratifying patients with pT3 or pT4a CRCs into three prognostically distinct groups. We recommend the subcategorisation of pT3 CRC by ELI for better prognostic assessment and treatment strategy of patients with CRC.
评估腹膜弹性层浸润(ELI)已被提议作为结直肠癌(CRC)pT3 的附加评估。其临床意义尚未确定。我们进行了一项荟萃分析,以研究 ELI 评估对 pT3 CRC 亚分类的预后影响。我们在三个电子数据库中进行了检索。使用随机效应模型,根据逆方差法加权,计算总生存(OS)和无病生存(DFS)的 HR 及其 95%CI。我们从最初的 703 项数据库检索中找到了 6 项符合纳入标准的研究。我们的荟萃分析纳入了 1925 例 pT3 和 pT4a CRC 患者。与 ELI 阴性 pT3 CRC 相比,pT3 CRC 中存在 ELI 与缩短 OS 相关(HR=1.76;95%CI 1.21 至 2.55);而 DFS 无统计学意义(HR=1.79;95%CI 0.91 至 3.52)。此外,pT4a 患者的 OS(HR=1.84;95%CI 1.41 至 2.40)和 DFS(HR=1.88;95%CI 1.17 至 3.04)甚至比 pT3 ELI(+)患者的 OS 和 DFS 更差。ELI 是将 pT3 或 pT4a CRC 患者分层为三个具有明显不同预后的有用标志物。我们建议根据 ELI 对 pT3 CRC 进行亚分类,以更好地评估 CRC 患者的预后并制定治疗策略。